PAM
AEON icon

Panagora Asset Management’s AEON Biopharma AEON Stock Holding History

Panagora Asset Management’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-11
Closed -$8K – 1711
2021
Q2 		$8K Buy
+11
New +$7.69K ﹤0.01% 2321

Other funds holding AEON

ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Panagora Asset Management's AEON Position: Q3 2021 in Review

Panagora Asset Management sold out of AEON Biopharma (AEON) in Q3 2021, closing a stake of 11 shares — an estimated $8K sold.

Panagora Asset Management first reported a position in AEON in Q2 2021 and held it in 1 quarter. The position peaked at $8K in Q2 2021. 59 funds tracked by Wall St. Rank hold AEON as of Q3 2021.

  • Panagora Asset Management reported no remaining AEON Biopharma position as of Q3 2021 after selling out during the quarter.
  • Panagora Asset Management sold 11 AEON Biopharma shares in Q3 2021, an estimated $8K.
  • Panagora Asset Management first reported a position in AEON Biopharma in Q2 2021 and held it in 1 quarter.
  • Panagora Asset Management's AEON Biopharma position peaked at $8K in Q2 2021.
  • 59 funds tracked by Wall St. Rank held AEON Biopharma as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.